Novartis Investigative Site

Campo Grande, Mato Grosso do Sul 79080-190

0 studies enrolling now · 1 studies all time

What they study most

Atherosclerosis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed